Sunny Ryan joined Menlo Therapeutics in March 2016 and is responsible for its finance operations. Ms. Ryan has 20+ years of finance and accounting experience, in public accounting and life sciences industry.
Prior to joining Menlo Therapeutics, Ms. Ryan was a controller at Velocity Pharmaceutical Development where she was overseeing the finance operations for several project focused companies including Menlo Therapeutics. In 2013 and 2014, she was an interim controller at Avalanche Biotechnologies where she worked on their initial public offering.
She began her career at PricewaterhouseCoopers where she spent over 8 years in audit advisory, tax and transaction services. Since then, Ms. Ryan held Controller and Senior Director of Finance positions at various life sciences companies including Genelabs Technologies, Rinat Neuroscience, CoMentis, Achaogen and Alios BioPharma where she was responsible for SEC filings, SOX implementation, M&A transactions and IPO readiness.
Ms. Ryan holds a B.S. in Accounting from Pepperdine University and is a Certified Public Accountant in California.